BACKSTOP AGREEMENTBackstop Agreement • October 22nd, 2020 • Tenzing Acquisition Corp. • Pharmaceutical preparations • New York
This Backstop Agreement (this “Agreement”) is made as of [____________], 2020 by and among (i) Tenzing Acquisition Corp., a company incorporated in the British Virgin Islands (together with its successors, including after the Conversion (as defined below), the “Company”), (ii) Reviva Pharmaceuticals, Inc., a Delaware corporation (together with its successors, “Reviva”), and (iii) [________________________], a [jurisdiction and type of entity] (“Investor”), and is intended to set forth certain representations, covenants and agreements among the Company, Reviva and Investor with respect to the acquisition by Investor of an aggregate of [___________________] (together with any replacement shares of Common Stock (as defined bellow) after the Conversion, the “Subject Shares”) ordinary shares, no par value, of the Company (“Ordinary Shares”) through the open market and private transactions described in Section 3 hereof. The respective representations, warranties, covenants and agreements set
